Performance of NVO Novo Nordisk A/S | 69.2% in 12m

Compare NVO with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Novo Nordisk A/S with its related Sector/Index XLV

Compare Novo Nordisk A/S with its related Sector/Index XLV

Performance Duell NVO vs XLV

TimeFrame NVO XLV
1 Day -1.44% -1.21%
1 Week -0.80% -2.45%
1 Month 5.67% 1.60%
3 Months 10.9% -1.93%
6 Months 32.9% 10.94%
12 Months 69.2% 14.42%
YTD 32.0% 3.17%
Rel. Perf. 1m 0.37
Rel. Perf. 3m 2.08
Rel. Perf. 6m 1.57
Rel. Perf. 12m 3.82

Is Novo Nordisk A/S a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, Novo Nordisk A/S (NYSE:NVO) is currently (May 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.86 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVO as of May 2024 is 173.06. This means that NVO is currently undervalued and has a potential upside of +29.07% (Margin of Safety).

Is NVO a buy, sell or hold?

  • Strong Buy: 5
  • Buy: 3
  • Hold: 1
  • Sell: 1
  • Strong Sell: 0
Novo Nordisk A/S has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy NVO.
Values above 0%: NVO is performing better - Values below 0%: NVO is underperforming

Compare NVO with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -0.51% 1.80% 15.57% 41.31%
US NASDAQ 100 QQQ -1.65% -0.55% 14.61% 37.01%
US Dow Jones Industrial 30 DIA 1.75% 4.27% 22.16% 49.46%
German DAX 40 DBXD -0.58% 2.88% 16.57% 52.67%
UK FTSE 100 ISFU 0.55% 2.04% 19.32% 51.85%
Shanghai Shenzhen CSI 300 CSI 300 1.47% 7.07% 32.43% 75.55%
Hongkong Hang Seng HSI 1.98% - 31.16% 75.34%
Japan Nikkei 225 EXX7 -0.13% 5.76% 22.01% 59.93%
India NIFTY 50 INDA -1.46% 3.71% 15.13% 40.88%
Brasil Bovespa EWZ 2.51% 9.92% 40.61% 58.46%

NVO Novo Nordisk A/S vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -1.22% 0.73% 14.72% 34.53%
Consumer Discretionary XLY 1.10% 8.39% 29.14% 53.88%
Consumer Staples XLP 1.29% 4.79% 22.78% 60.76%
Energy XLE 0.87% 9.90% 21.88% 46.73%
Financial XLF 1.64% 4.71% 15.12% 38.75%
Health Care XLV 1.65% 4.07% 21.93% 54.81%
Industrial XLI 0.97% 6.11% 15.33% 41.92%
Materials XLB 0.58% 4.85% 19.57% 46.74%
Real Estate XLRE 2.73% 4.96% 29.79% 61.84%
Technology XLK -1.47% -2.01% 15.45% 37.72%
Utilities XLU 1.18% -0.80% 17.46% 54.39%
Aerospace & Defense XAR 0.55% 1.57% 19.08% 40.36%
Biotech XBI 1.86% 1.45% 10.80% 62.00%
Homebuilder XHB 2.45% 6.45% 5.83% 20.61%
Retail XRT -0.53% 3.07% 14.95% 39.15%

NVO Novo Nordisk A/S vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -2.77% 7.98% 23.89% 44.58%
Natural Gas UNG -0.13% -24.18% 45.19% 92.77%
Gold GLD 1.89% 4.74% 17.58% 49.37%
Silver SLV -0.70% -12.09% 5.30% 31.95%
Copper CPER 3.92% 2.89% 7.24% 36.69%

Returns of NVO vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.86% 4.09% 32.46% 77.66%
iShares High Yield Corp. Bond HYG -0.18% 5.23% 27.94% 59.49%
Does Novo Nordisk A/S outperform its market, is NVO a Sector Leader?
Yes, over the last 12 months Novo Nordisk A/S (NVO) made 69.23%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 14.42%.
Over the last 3 months NVO made 10.88%, while XLV made -1.93%.
Period NVO XLV S&P 500
1 Month 5.67% 1.60% 3.87%
3 Months 10.88% -1.93% 4.98%
12 Months 69.23% 14.42% 27.92%